KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Prepaid Assets (2018 - 2025)

Vir Biotechnology's Prepaid Assets history spans 8 years, with the latest figure at $45.1 million for Q4 2025.

  • On a quarterly basis, Prepaid Assets fell 5.41% to $45.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $45.1 million, a 5.41% decrease, with the full-year FY2025 number at $45.1 million, down 5.41% from a year prior.
  • Prepaid Assets hit $45.1 million in Q4 2025 for Vir Biotechnology, up from $37.0 million in the prior quarter.
  • Over the last five years, Prepaid Assets for VIR hit a ceiling of $104.4 million in Q4 2022 and a floor of $4.1 million in Q1 2024.
  • Historically, Prepaid Assets has averaged $49.1 million across 5 years, with a median of $44.1 million in 2024.
  • Biggest five-year swings in Prepaid Assets: plummeted 95.8% in 2024 and later soared 934.0% in 2025.
  • Tracing VIR's Prepaid Assets over 5 years: stood at $73.0 million in 2021, then soared by 42.95% to $104.4 million in 2022, then plummeted by 49.64% to $52.5 million in 2023, then fell by 9.18% to $47.7 million in 2024, then fell by 5.41% to $45.1 million in 2025.
  • Business Quant data shows Prepaid Assets for VIR at $45.1 million in Q4 2025, $37.0 million in Q3 2025, and $41.5 million in Q2 2025.